Omeros | OMER - Market Capitalization


Omeros reported $720.4M in Market Capitalization this May of 2026, considering the latest stock price and the number of outstanding shares.





Market Capitalization Change Date
Adma Biologics USD 4.34B 845M Dec/2025
Alnylam Pharmaceuticals USD 44.15B 8.39B Mar/2026
BioMarin Pharmaceutical USD 10.18B 683M May/2026
Cytokinetics USD 9.16B 975M May/2026
Gilead Sciences USD 167.39B 5.6B May/2026
Heron Therapeutics USD 238M 7M Dec/2025
Immunic USD 64M 23M Dec/2025
Insmed USD 15.56B 19.73B May/2026
Knight Therapeutics CAD 600.53M 14.56M Dec/2025
MacroGenics USD 102M 4M Dec/2025
Pacira USD 915M 149M Mar/2026
Pfizer USD 147.4B 6.42B May/2026
Sarepta Therapeutics USD 2.16B 123M May/2026
United Therapeutics USD 28.08B 2.9B May/2026
Vertex Pharmaceuticals USD 113.58B 1000K May/2026